Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Maturin, neural progenitor differentiation regulator homolog (MTURN), is a protein-coding gene located on chromosome 7. MTURN is implicated in promoting megakaryocyte differentiation, mainly through enhancement of ERK and JNK signaling pathways and upregulation of RUNX1 and FLI1 expression. It also represses NF-kappaB transcriptional activity by inhibiting phosphorylation of RELA at Ser-536, which is linked to inflammation regulation. MTURN may play a role in early neuronal development. High expression of MTURN has been associated with lung cancer. The protein is cytoplasmic and relates to various disease processes but is not currently considered a canonical drug target, and there are no reported interacting drugs or direct mechanisms of action for therapeutic intervention[1][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Maturin, neural progenitor differentiation regulator homolog (MTURN).